Gregory Goldmacher MBA, MD, PhD

Gregory Goldmacher is Executive Director in the Translational Biomarkers department at the Merck Research Laboratories. He obtained his Bachelor’s degree in biological sciences from the University of Chicago, and his MD and PhD (in neuroscience) at the UT Southwestern Medical Center in Dallas. He did residency training in diagnostic radiology, and was a fellow at the Massachusetts General Hospital and at Thomas Jefferson University.

He also obtained an MBA from Temple University, with a finance focus. Prior to joining Merck, he was the head of cancer imaging at ICON. At Merck, he has led imaging across many late and early phase oncology programs. He has also led internal research efforts and external collaborations focused on applying artificial intelligence to the development of novel biomarkers for use in oncology trials and clinical care. He is active in clinical trial research and standardization efforts, with participation and high-level leadership in a variety of national collaborations such as the Quantitative Imaging Biomarkers Alliance and the Clinical Data Interchange Standards Consortium. He spends most of his free time playing with his kids, but also enjoys running and training in the martial arts.